Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

ClinicalTrials.gov ID: NCT05454189

Public ClinicalTrials.gov record NCT05454189. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 1:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Randomized Study To Evaluate The Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12 Weeks

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Implanted port devices (IPD) play an essential role in the safe administration of cancer treatments by providing a device to safely administer caustic chemotherapy agents. The current recommended frequency of flushing the IPD per manufacturers guidelines is every 4-6 weeks. The purpose of this study is to find out if extending IPD flushes to every 12 weeks is safe and if it is just as effective as every 4 week flushing.

Study identification

NCT ID
NCT05454189
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Essentia Health
Other
Enrollment
400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 10, 2022
Primary completion
Jun 30, 2025
Completion
Dec 30, 2026
Last update posted
May 19, 2026

2022 – 2026

United States locations

U.S. sites
17
U.S. states
2
U.S. cities
16
Facility City State ZIP Site status
Mayo Clinic Health System - Albert Lea Albert Lea Minnesota 56007
Essentia Health St. Joseph's Medical Center Brainerd Minnesota 56401
Essentia Health Deer River Clinic Deer River Minnesota 56636
Essentia Health St Mary's Detroit Lakes Clinic Detroit Lakes Minnesota 56501
Essentia Health Duluth Clinic Duluth Minnesota 55805
Essentia Health Fosston Fosston Minnesota 56542
Fairview Grand Itasca Clinic & Hospital Grand Rapids Minnesota 55744
Essentia Health Hibbing Clinic Hibbing Minnesota 55746
Fairview Range Medical Center Hibbing Minnesota 55746
Mayo Clinic Health System - Mankato Mankato Minnesota 56001
Monticello Cancer center Monticello Minnesota 55362
Essentia Health Park Rapids Park Rapids Minnesota 56470
Fairview Northland Medical Center Princeton Minnesota 55371
Essentia Health Sandstone Sandstone Minnesota 55072
Essentia Health Virginia Clinic Virginia Minnesota 55792
Sanford Worthington Medical Center Worthington Minnesota 56187
Essentia Health Fargo Fargo North Dakota 58103

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05454189, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2026 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05454189 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →